Comparable stake leader
BAKER BROS. ADVISORS LP
SEC ownership of DBV Technologies S.A.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001613780.
Disclosed value leader
MPM BioImpact LLC
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Public ticker
- DBVT on Nasdaq, DBVTF on OTC
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BAKER BROS. ADVISORS LP
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BAKER BROS. ADVISORS LP
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001613780
- Issuer location
- Chatillon, France
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of DBV Technologies S.A. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
MPM BioImpact LLC
Comparable rows
50/50
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
13D/G row: BAKER BROS. ADVISORS LP
Showing 1-8 of 50 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 10%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
10%
SUVRETTA CAPITAL MANAGEMENT, LLC
9.9%
MPM BioImpact LLC
8.8%
JANUS HENDERSON GROUP PLC
8.8%
Adage Capital Management, L.P.
7.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13D/G
3/4/5
13F
Director · Company
|
10%
|
$490,489,821
25,586,190 shares
|
+$40,190,632 | 12 Jan 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13D/G
|
9.9%
|
$129,451,408
15,176,015 shares
|
$0 | 07 Apr 2025 |
| MPM BioImpact LLC |
13D/G
13F
Company
|
8.8%
|
$577,119,085
26,066,806 shares
|
+$32,933,228 | 31 Mar 2026 |
| JANUS HENDERSON GROUP PLC |
13D/G
|
8.8%
|
—
20,469,392 shares
|
$0 | 31 Dec 2025 |
| Adage Capital Management, L.P. |
13D/G
|
7.3%
|
$493,121,652
22,272,884 shares
|
+$169,557,751 | 31 Mar 2026 |
| Invus Global Management, LLC |
13D/G
Raymond Debbane
|
6.5%
|
$427,523,511
19,310,005 shares
|
+$109,793,256 | 31 Mar 2026 |
| Bpifrance Participations SA |
13D/G
Caisse des Depots
|
4.7%
|
$208,927,156
10,898,595 shares
|
-$1,663,524 | 05 Jan 2026 |
| Vivo Opportunity Fund Holdings, L.P. |
13D/G
|
4%
|
—
11,820,005 shares
|
$0 | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$15,510,975.
Buys
$0
Insiders: 0
Sells
$15,510,975
Insiders: 2
Net
-$15,510,975
Shares: -3,378,211
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 3,378,211
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 534 | $0 | $2,595 | -$2,595 |
| 6-9 | 0 | 3,377,213 | $0 | $15,507,350 | -$15,507,350 |
| 9-12 | 0 | 464 | $0 | $1,030 | -$1,030 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to DBV Technologies S.A.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
Bpifrance Epic
Net 12M change
-$15,510,975
Latest report
29 Jan 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Bpifrance Epic | Member of 10% owner group | $33,531,799 | -$15,484,143 | -32% | Mixed | 17 Dec 2025 |
| Bpifrance SA | 10%+ Owner | $9,263,806 | Mixed | 27 Mar 2025 | ||
| Bpifrance Investissement S.A.S. | Member of 10% owner group | $1,542,113 | Mixed | 27 Mar 2025 | ||
| Virginie Boucinha | Chief Financial Officer | $986,300 | Mixed | 21 Nov 2025 | ||
| Kevin Michael Trapp | Chief Commercial Officer | $774,950 | Mixed | 21 Nov 2025 | ||
| Pharis Mohideen | Chief Medical Officer | $704,675 | -$26,832 | -3.7% | Filing P/S | 29 Jan 2026 |
| Sebastien Robitaille | Chief Financial Officer | $63,510 | Mixed | 21 Nov 2022 | ||
| Daniel B. Soland | Director | $34,800 | Mixed | 01 Aug 2023 | ||
| Timothy E. Morris | Director | $20,880 | Mixed | 25 Aug 2023 | ||
| Adora Ndu | Director | $1,624 | Filing P/S | 06 Feb 2024 | ||
| Philina Lee | Director | Mixed | 30 Oct 2025 | |||
| Daniel Tasse | CHIEF EXECUTIVE OFFICER, Director | Mixed | 21 Nov 2025 | |||
| BAKER BROS. ADVISORS LP | Director | Mixed | 12 Jan 2026 | |||
| Madduri Ravin Rao | Director | Mixed | 10 Jun 2021 | |||
| Viviane Monges | Director | Mixed | 10 Jun 2021 | |||
| Michel de Rosen | Director | Mixed | 10 Jun 2021 | |||
| Daniele Guyot-Caparros | Director | Mixed | 03 Oct 2022 |
Recent insider transactions for DBV Technologies S.A.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharis Mohideen | DBVT | Ordinary Shares | Sale | -0.37% | $2,595 | $4.86 | -534 | 144,995 | 29 Jan 2026 | Direct |
| Baker Bros. Advisors Lp | DBVT | Second Pre-Funded Warrant | Options Exercise | 27,304,896 | 25,005,240 | 12 Jan 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | DBVT | BS Warrant | Options Exercise | -100% | -27,304,896 | 0 | 12 Jan 2026 | See Footnotes | ||
| Bpifrance Epic | DBVT | Ordinary Shares | Sale | -15% | $5,413,912 | $4.19 | -1,292,103 | 7,303,369 | 18 Dec 2025 | By Bpifrance Participations S.A. |
| Bpifrance Epic | DBVT | Ordinary Shares | Sale | -19.5% | $10,070,232 | $4.85 | -2,076,990 | 8,595,472 | 17 Dec 2025 | By Bpifrance Participations S.A. |
| Pharis Mohideen | DBVT | Ordinary Shares | Award | 43.3% | 44,000 | 145,529 | 21 Nov 2025 | Direct | ||
| Pharis Mohideen | DBVT | Ordinary Shares | Sale | -1.57% | $4,498 | $2.77 | -1,624 | 101,529 | 21 Nov 2025 | Direct |
| Pharis Mohideen | DBVT | Employee Stock Option (right to buy) | Award | 253,000 | 253,000 | 21 Nov 2025 | Direct | |||
| Virginie Boucinha | DBVT | Ordinary Shares | Award | 84.2% | 32,000 | 70,000 | 21 Nov 2025 | Direct | ||
| Virginie Boucinha | DBVT | Employee Stock Option (right to buy) | Award | 192,000 | 192,000 | 21 Nov 2025 | Direct | |||
| Kevin Michael Trapp | DBVT | Ordinary Shares | Award | 55,000 | 55,000 | 21 Nov 2025 | Direct | |||
| Kevin Michael Trapp | DBVT | Employee Stock Option (right to buy) | Award | 316,250 | 316,250 | 21 Nov 2025 | Direct | |||
| Daniel Tasse | DBVT | Employee Stock Option (right to buy) | Award | 964,000 | 964,000 | 21 Nov 2025 | Direct | |||
| Pharis Mohideen | DBVT | Ordinary Shares | Sale | -5.92% | $18,708 | $2.88 | -6,496 | 103,153 | 20 Nov 2025 | Direct |
| Pharis Mohideen | DBVT | Ordinary Shares | Sale | -0.42% | $1,030 | $2.22 | -464 | 109,649 | 29 Jul 2025 | Direct |
* marks a reported price that did not pass the local price check.